Making A DifferenceDespite Evidence Of Rare Blood Clot Risk, US To Resume Use Of J&J’s Covid-19 VaccineBY Associated Press
NationalRemdesivir An 'Investigational Drug', Not Suitable For Home Use: Niti AayogBY Outlook Web Bureau
Making A DifferenceUS: Johnson & Johnson Begins Testing Covid-19 Vaccines On TeenagersBY Associated Press
Making A DifferenceJ&J To Pay Rs 890 Cr To Woman Who Alleged Company’s Talcum Powder Contains Cancerous AgentsBY Outlook Web Bureau
NationalJohnson And Johnson Baby Shampoo Samples Fail Indian Quality Test, Company Rejects FindingsBY Outlook Web Bureau
.jpg?auto=format%2Ccompress&fit=max&format=webp&w=300&dpr=1.0)
